CBD Forum by Chow420

Go back
Refer
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Cannabis Ballot Initiative Title Rejected by Arkansas Attorney General

Arkansas Attorney General Tim Griffin recently rejected a medical cannabis ballot measure because of its title. The Arkansas Medical Cannabis Amendment of 2024 was submitted on Jan. 12 by Stephen Lancaster of the law firm Wright Lindsey & Jennings LLP. Griffin responded to the submission, although the opinion was initially prepared by Assistant Attorney General William R. Olson on Jan. 29, explaining the reasoning behind his decision to reject the measure in its current form. He clearly states in the beginning of this letter that his decision is not a reflection of his support or opposition to this ballot measure, or any others. “My decision to certify or reject a popular name and ballot title is unrelated to my view of the proposed measure’s merits,” Griffin began. “I am not authorized to consider the measure’s merits when considering certification.” However, ballot titles are required to be written in a very specific way. Those who write the measures must ensure that the titles contain all of the essential facts “which would give the voter serious ground for reflection,” but also attempt to keep it brief. “The ballot title is not required to be perfect, nor is it reasonable to expect the title to address every possible legal argument the proposed measure might evoke,” Griffin explained. “The title, however, must be free from any misleading tendency—whether by amplification, omission, or fallacy—and it must not be tinged with partisan coloring. The ballot title must be honest and impartial, and it must convey an intelligible idea of the scope and significance of a proposed change in the law.” Griffin continued to share the core reason behind the rejection, explaining that the title was not formatted properly and contained ambiguous statements. “Where the effects of a proposed measure on current law are unclear or ambiguous, I am unable to ensure the popular name and ballot title accurately reflect the proposal’s contents until the sponsor clarifies or removes the ambiguities in the proposal itself.” Griffin is sending the ballot measure authors back to the drawing board to fix the wording. The header, for instance, currently reads “Be it Enacted by the People of the State of Arkansas,” but wording including “enacting clauses” is only required for bills, not constitutional amendments, which may cause voters to be unsure if this is a bill or a constitutional amendment. He also suggested new text to a section that discusses advertising, and ambiguous wording for “rules shall also require child-proof packaging,” addresses that “medical cannabis” as a phrase is not defined anywhere, noting that the interchangeable use of “marijuana plants” and “cannabis plants” be just “cannabis plants” to avoid confusion, and more. If the Arkansas Medical Cannabis Amendment of 2024 is passed, it would amend the constitution to allow patients and caregivers to cultivate up to seven mature cannabis plants, as well as seven younger plants, expand the qualifying conditions of medical cannabis to include more than the current 18 conditions, allow out-of-state patients holding medical cannabis cards to purchase cannabis in Arkansas, remove fees for cannabis card applications, and allow those cards to last for three years instead of one. It also includes a section entitled “Effect of future federal classification of marijuana” which would permit possession of up to one ounce of cannabis if the federal government decides to remove cannabis from the list of controlled substances. The Arkansas Advocate published an article on this topic and noted that the advocate group can only begin collecting signatures once Griffin has signed off on a ballot measure. After that, they have until July 5 to submit 90,704 signatures in order to qualify for the ballot in November. Erika Gee, an attorney representing Arkansans for Patient Access, shared a statement with the news outlet regarding what’s next. “Arkansans for Patient Access is reviewing Attorney General Tim Griffin’s ballot proposal opinion. We intend to address the issues raised and resubmit,” Gee said. “We are confident ballot language will be presented that ultimately gains approval.” Arkansas voters legalized medical cannabis in November 2016 through Amendment 98, and sales began in May 2019. In August 2022, a recreational cannabis ballot initiative from Responsible Growth Arkansas was rejected because of its name and title. The group quickly filed a lawsuit  “to challenge the State Board of Election Commissioners’ thwarting of the will of the people and their right to adopt laws by initiative.” The Arkansas Supreme Court said that the measure would still appear on the ballot, as Arkansa Issue 4. However, in November 2022, 56.25% of voters voted no, while only 43.75% voted yes. Late last year, the Arkansas Medical Marijuana Commission announced that medical cannabis taxes were helping to fund kids’ school lunches in the state. The commission stated that while the state collected $115 million from cannabis taxes, an estimated $87 million was granted for food insecurity.

https://hightimes.com/

Alaska Lawmaker Introduces Psychedelics Task Force Bill

An Alaska lawmaker has introduced a bill to create a task force to study the potential medical uses of psychedelic drugs including psilocybin and MDMA. The legislation, Senate Bill 166, was introduced earlier this month by Democratic state Senator Forrest Dunbar. If passed by the legislature and signed into law by Republican Governor Mike Dunleavy, Dunbar’s bill would establish a task force that would be given one year to study how psychedelics might be used to address Alaska’s mental health challenges. The task force would investigate paths to legalize psychedelics, requirements for licensing and insurance, and barriers to access to the drugs. “We want Alaska to have a regulatory framework to potentially allow medical providers to use the substances, which had been shown in sort of the early data of the tests to potentially have really positive impacts on people dealing with trauma and with addiction,” Dunbar said in a statement, according to a report from Alaska Public Media.  The psychedelics task force created by the legislation would consist of people representing the healthcare needs of Alaska Natives, military veterans and survivors of domestic abuse and sexual assault. Dunbar said it is important to include Alaska Natives in the task force, noting that other states have not included representation of Indigenous communities and traditional healers in their discussions about psychedelics policy reform. Dunbar introduced Senate Bill 166 in anticipation of a potential change in the legal status of psychedelic drugs at the federal level. Clinical research and other studies into psychedelics such as psilocybin and MDMA have shown that the drugs have potential therapeutic benefits, particularly for serious mental health conditions such as depression, PTSD, substance misuse disorders and anxiety.  “It doesn’t work for everyone, but there are certainly people who could access these substances and potentially have life changing medical results,” Dunbar said. Research published in the peer-reviewed journal JAMA Psychiatry in 2020 found that psilocybin-assisted psychotherapy was an effective and quick-acting treatment for a group of 24 participants with major depressive disorder. A separate study published in 2016 determined that psilocybin treatment produced substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer. In 2017, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for psychotherapy utilizing MDMA, the psychedelic drug commonly known as Ecstasy, indicating that the therapy is a significant improvement over existing treatments. Last month, MAPS Public Benefit Corporation (MAPS PBC), a subsidiary of the groundbreaking psychedelics nonprofit advocacy group the Multidisciplinary Association for Psychedelic Studies (MAPS), announced it had submitted an application seeking FDA approval for MDMA-assisted therapy. Only weeks later, the organization announced it had changed its name to Lykos Therapeutics and had raised $100 million in financing to develop psychedelic therapies. As the research continues, Dunbar said it is important to address psychedelics policy including current prohibition and potential legalization so the drugs will be available to people who can benefit from them. “The hope is because these are medical treatments that we would find a way to bill insurance like anything else,” Dunbar said. “How do we make sure we can bill Medicaid and bill private insurance? And I know the indigenous community in particular needs to think about, and will help guide the task force, so that we can make sure we’re getting funds into the traditional healers’ hands as well.” Melissa Bradley, an epidemiologist based in Anchorage who studies psychedelic medicines, said that she became interested in the field after seeing the strong research data. She notes that psychedelic therapy is not an easy undertaking. Many patients find the experience challenging or upsetting during treatment, but long-lasting improvements in mental health have been reported for many patients.  Most research into the therapeutic potential of psychedelics is conducted in a controlled environment. Although the method is effective, finding ways to use the drugs in other, less controlled settings could be the key to greatly expanding access to psychedelic therapy.  “To really figure out the mystery of psychedelics is figuring out the mysteries of consciousness,” Bradley said. “And, we’re kind of poking at that, on the research side of things, but it’s also moving forward, in terms of policy. And so, it will be kind of a Wild West in terms of policy and regulations.” Dunbar’s bill has been referred to the Senate Labor and Commerce Committee for consideration. Democratic State Representative Jennifer Armstrong has filed companion legislation to Senate Bill 166 in the Alaska House of Representatives, where the measure has been assigned to the Health and Social Services Committee. No hearings have yet been planned for the bills, but Dunbar said he hopes to have one scheduled for early February.

https://hightimes.com/

Psilocybin Treatment Bill Proposed in Hawaii

A new bill was introduced in Hawaii last week on Jan. 24, which aims to establish a regulatory framework for therapeutic psilocybin if passed. However, in its current form, the bill would help protect patients who choose that form of medicine, rather than fully legalize psilocybin. Senate Bill 3019 was introduced by Sen. Chris Lee on Jan. 24, and a companion bill, House Bill 2630, was introduced on Jan. 23 by 14 representatives. “…the purpose of this Act is to ensure that people who struggle with trauma and treatment-resistant mental health ailments are not penalized by the State for the use of psilocybin for therapeutic purposes when the patient’s licensed mental health professional provides a professional recommendation that the benefits of therapeutic use of psilocybin would likely outweigh the health risks for the qualifying patient,” the bill stated. Additionally, should any psilocybin products or paraphernalia be seized by law enforcement and a defendant proves in court that they consume legally through the program, law enforcement would be forced to return the products. However, if any patient attempts to claim they use psilocybin for therapeutic purposes to avoid arrest, they will be charged $500. According to SB 319, the benefits of the bill would be limited to those who have a high school diploma or equivalent degree, are currently 21 years or older, must be a resident in Hawaii, and would have to undergo a “psychedelic integration training program” that has been approved by the Office of Wellness and Resilience (OWR). Once a person qualifies, they could potentially gain access to psilocybin treatment if they suffer from any of the following conditions: “post-traumatic stress disorder (PTSD), treatment-resistant depression or major depressive disorder, end-of-life anxiety, existential stress, and demoralization, anorexia, bulimia, and other eating disorders, addiction, obsessive compulsive disorder.” Additionally, other mental health conditions could also qualify for psilocybin if it’s approved by the Department of Health and requested by a licensed mental health professional. Therapy sessions would be structured in three phases. First, the preparation session, which would allow the patient to meet with a facilitator. Second, the administration session, where the patient “purchases, consumes, and experiences the effects of psilocybin” while the facilitator supervises. Finally, an integration session would be held, which would allow the facilitator to offer care for the patient and inform them about peer support and other resources that could be beneficial to them. The OWR announced in August that the Breakthrough Therapies Task Force held its first meeting on Aug. 29, 2023. Its role is to prepare how to implement therapeutic programs that include MDMA and psilocybin. Lee is one of the members, in addition to 10 others, who are members of the task force. Hawaiian legislators’ approach to psilocybin treatment is much different than the way similar laws have been crafted in states such as Oregon and Colorado. The first psilocybin treatment center to be licensed and to begin operating in Oregon, EPIC Healing Eugene, had thousands of people waitlisted just three months after it opened in June 2023. An end of year report stated that by the end of 2023, more than 700 people had experienced psilocybin at treatment centers across the state. Colorado’s psychedelics bill was passed by voters in 2022 and signed by Gov. Jared Polis in May 2023. It removed criminal penalties for possession and consumption of substances such as psilocybin, ibogaine, mescaline, and DMT. These substances can also be shared (ibogaine is the only exception), but not sold, and it permits the home cultivation of mushrooms within a 12 x 12 foot space. In November 2023, Hawaii Attorney General Anne Lopez announced a 294-page plan to legalize adult-use cannabis. The proposal included a 4.25% excise tax on adult-use products, plus a 10% tax on surcharge. It also included a way for illegal cultivators to enter the legal industry by providing grants through a social equity program. “The most important thing we can do is we can bring the people who have been growing and selling marijuana illegally into the legal market,” Lopez said. Medical cannabis dispensaries that have already gone through the hurdles of licensing would be among the first to sell in a recreational market. “They’re already standing up, they’re already growing, they are already prepared to go to market,” Lopez explained. Some legislators expressed their approval of Lopez’s proposal late last year, including House Judiciary Chair David Tarnas. “The attorney general has done a really good job pulling together all of the different input and providing a comprehensive bill,” Tarnas said. Sen. Jarrett Keohokalole called it “the best version to date. And part of it is the efforts to try and address a lot of the issues that came up along the way.”

https://hightimes.com/

Leaders, International Authorities Unite After Historic Fiji Drug Bust

Police seized nearly five tons of methamphetamine in Fiji, equivalent to more than $2 billion in Fijian dollars (approximately $886.2 million USD). The first Jan. 14 raid resulted in seizure of more than three tons of meth at a warehouse on the western side of Fiji’s main island near the country’s main international airport, according to an OCCRP report. The second raid took place Jan. 20, with Fiji’s public prosecutor sanctioning charges against 13 people in connection to the raids, RNZ reports. Those accused have been charged with unlawful possession of illicit drugs, according to a statement from the Office of the Director of Public Prosecutions (ODPP). “Of the 13 accused persons, two are also charged with unlawful importation of illicit drugs. It is alleged that the accused persons without lawful authority, facilitated the importation and were found in possession of 4.8 tonnes of methamphetamines, an illicit drug, the statement says. The ODPP also said that three of the 13 suspects were also charged with possession of property suspected of being proceeds of crime. “It is alleged that the three accused persons were found in possession of cash (local and overseas currency) suspected of being proceeds of crime,” the statement said. One of the 13, Justin Ho, was previously charged for exporting 2015.7 grams of cocaine from Sydney in 2018 while working as a flight attendant for Fiji Airways. Ho, and the other suspect, ended up walking free after the drugs went missing from the Namaka Police Station and the ODPP filed to discontinue proceedings. A Fijian police officer was also charged in relation to the incident, after allegedly scooping up what was believed to be crystal meth powder from the first drug bust. The officer also allegedly fled the scene on Jan. 14 and was apprehended two days later. A Fiji court proceeded to grant bail to the 13 people charged after questioning and holding them in custody for 48 hours per country law. They are still under a curfew and must appear at the Lautoka High Court on Friday.  Fiji Police are now working with their nearby counterparts, like the Australian Federal Police and the Pacific Transnational Crime and Coordination Centre, and expect to make additional arrests. According to Fiji Police Assistant Police Commissioner Mesake Waqa, the drugs arrived in Fiji in late December and the country was “being used as a transit point and that the methamphetamine was destined for a foreign market.” Waqa also said that the exchange of the meth shipment was believed to have been made outside of the country’s Exclusive Economic Zone, and the packages were delivered through a barge. “The Fiji Police Force will not be making further comments on the ongoing investigation until major developments are made,” Waqa said. According to the Fiji Sun, three chiefs — Tui Nadi Ratu Vuniyani Navuniuci, Tui Sabeto Ratu Viliame Mataitoga and Tui Nawaka Ratu Joeli Naevo — have also united to address the issue and naming their concern about drugs in the country. It’s looking as though this incident could ignite a War on Drugs in the region, as entities like the Nadi Chamber of Commerce and Nadi Town Council also urged for swift action to address what they called a “serious and worrying issue.”  Dr. Ram Raju, president of the Nadi Chamber of Commerce and Industry, said that these drug busts were staggering and that Fiji is vulnerable acting as a middle country for illegal drug trade. Raju similarly called for major, sweeping measures, even suggesting that Fiji be deemed as “smoke and drug free.” Pio Tikoduadua, Fijian Parliament minister and member, pointed to the need for legislative review and strengthening the country’s laws around illicit drug trade and border control. Tikoduadua also called for harsher penalties on those involved in the drug trade and building effective processes for police investigations while emphasizing that education is one of the best tools to discourage Fijians from using drugs.

https://hightimes.com/

South Dakota Legislators Shut Down Bill Restricting Medical Cannabis Access for Patients

South Dakota members of the Senate Health and Human Services Committee, with a vote of 5-2, decided last Wednesday to postpone any additional proceedings regarding legislation (SB 82), which aims to limit the medical cannabis access to a sweeping number of patients, NORML reports.  The proposed bill aimed to limit patients to receiving medical cannabis recommendations exclusively from their primary care physician or other healthcare providers suggested by their primary doctor. Any doctors who provided recommendations but did not comply with the bill’s strict criteria would have faced criminal charges. As South Dakota Searchlight reports, out of nine bills proposed to modify South Dakota’s medical cannabis regulations in this legislative session in Pierre, seven are still under review. These include measures to increase the cost of dispensary licenses, authorize cops to search dispensaries, and require prescribers to inform a patient’s primary care doctor when they get their medical cannabis card. According to Jeremiah Murphy, a lobbyist for the Cannabis Industry Association of South Dakota, the good (if you can call it that), news is that of the nine bills, the shut down Senate Bill 82 was the most troubling. It would have made it significantly easier for doctors who offer medical cannabis as a treatment option to face criminal charges. “Senate Bill 82 was absolutely the most critical threat out of what’s out there,” Murphy told South Dakota Searchlight. “They got a lot of feedback from patients on that one. They poked the beehive, and bees came out.”  In his testimony, Murphy stressed that 30% of Americans do not have a primary care physician.  The potential for criminal charges against doctors was a crucial consideration for Sen. Erin Tobin, R-Winner. Tobin, a nurse by profession and chair of the Senate Health and Human Services Committee, also serves on the Medical Marijuana Oversight Committee alongside the bill’s sponsor, Sen. Jim Mehlhaff, R-Pierre. For Tobin, a major issue with the bill was its effort to legally define “primary care provider,” a term and profession that’s tricky to concretely specify due to the flexible nature of roles within our healthcare system. Some folks see specialty doctors for their primary care, others rely on clinics. Putting aside all the War on Drugs rhetoric within the bill, we simply don’t have a solid, organized enough health care system for it to make sense.  Tobin challenged that should the bill pass, doctors who fall somewhere in the gray area, or would as a result, be quite hesitant to prescribe cannabis to patients who would otherwise benefit from it. “If there’s a questionable piece to this, doctors are just going to pull out,” Tobin noted. Back in 2020, South Dakota’s electorate voted to legalize medical cannabis, as favored by 74% of voters. As often happens, in the year since, anti-cannabis lawmakers have put concerted effort into dialing back or revoking this law however possible. There are presently more than 13,000 residents who are officially registered with the state for medical marijuana access, and over 250 practitioners are authorized to provide cannabis recommendations. Opponents additionally pointed to the lack of solid evidence suggesting that anyone is taking advantage of this current system. One must also keep in mind how it would impact the veterans, who often greatly benefit from cannabis for PTSD, who see a primary doctor through the Veterans Affairs Health System. VA doctors currently aren’t allowed to prescribe cannabis. This could be changing.  As High Times reported, in June of 2023, the Senate Appropriations Committee passed a budget bill that incorporates an amendment permitting doctors from the VA to recommend medical cannabis to their patients in states where it’s legal. This amendment is now part of the sanctioned legislation set to finance the VA for the Fiscal Year 2024. The amendment, approved through a voice vote and introduced by Senator Jeff Merkley, an Oregon Democrat, aims for outcomes similar to those in a House-reintroduced bipartisan bill. This bill has the support of Oregon Democrat Representative Earl Blumenauer and Florida Republican Representative Brian Mast, an Army veteran who lost both legs in Afghanistan. Blumenauer and Mast jointly serve as co-chairs of the Congressional Cannabis Caucus. Senator Merkley explained that the recently passed measure in The Senate Appropriations Committee “simply says, in states that have a medical cannabis program, that a veteran’s doctor can talk to their veteran patient about the pros and cons of medical cannabis and fill out related paperwork should a veteran decide to participate in a state program where such paperwork is required.” Back in South Dakota, it’s also important to understand the challenge faced by Native American citizens in finding a primary care doctor. Often, the only viable healthcare option available on these reservations are the physicians at the Indian Health Service (IHS). Similar to the VA, the IHS prohibits its doctors from prescribing medical cannabis, as it remains illegal under federal law. 

https://hightimes.com/

Exclusive: Sen. Kirsten Gillibrand Calls on Biden Administration To Deschedule Cannabis

Sen. Kirsten Gillibrand wants to send the Biden administration a message: End prohibition of cannabis, once and for all, by fully descheduling it rather than simply rescheduling it to a slightly less restrictive category. The time is right for real change. On Sunday, the senator called for Attorney General Merrick Garland and the U.S. Drug Enforcement Administration (DEA) to act to deschedule cannabis at a press conference in Harlem, New York. Cannabis is currently classified as a schedule 1 controlled substance, the most restrictive category and the same as heroin, with “no currently accepted medical use.” “Descheduling marijuana from the Controlled Substances Act is not just a social justice issue; it’s an economic, medical, and public safety issue. Since marijuana was classified as a Schedule I substance during the war on drugs, countless lives have been torn apart, and individuals in primarily Black and brown communities have been targeted for nonviolent cannabis-related offenses,” Gillibrand said. “Studies show that legalizing marijuana could help reduce violence in international drug trafficking and generate billions of dollars for the economy. The vast majority of Americans agree that marijuana should be legalized—that’s why I’m calling on the Attorney General and the Drug Enforcement Administration to swiftly deschedule marijuana from the Controlled Substances Act.” Most recently, the U.S. Department of Health and Human Services (HHS) recommended that the DEA move cannabis to schedule III after careful review by federal authorities, but that may not be enough. High Times asked the senator why it’s critical to deschedule cannabis entirely, versus simply moving it to a less restrictive category. “Rescheduling marijuana will not correct the wrongs of our current judicial system, which has historically targeted Black and brown communities for marijuana related offenses,” Gillibrand told High Times.  The senator continued, “Descheduling marijuana is a critical step toward decriminalization, and it could also reduce violence in international drug trafficking, make the United States competitive in global markets, and generate billions of dollars for the economy.” Gillibrand is joined by Congressman Jerrold Nadler, New York State Senator Cordell Cleare, New York City Council Member Yusef Salaam, New York State Assemblymember Eddie Gibbs, New York State Assemblymember Rev. Al Taylor, Executive Director of Empire State NORML David Holland, and business leaders across New York. Gillibrand also reiterated her stance on social media as the 2024 general election gears up. “Classifying marijuana as a Schedule I drug—something more dangerous than cocaine or fentanyl—has harmed communities and denied critical relief to vulnerable patients,” the senator posted on X. “It’s time to legalize and deschedule marijuana altogether.” The current status of cannabis at the federal level puts individuals at risk, some more than others. The senator has voiced her opinion that cannabis should be legal at the federal level several times before, including the campaign trail of the 2020 general election. In 2017, Gillibrand introduced the Compassionate Access, Research Expansion and Respect (CARERS) Act with Al Franken, Rand Paul, and Cory Booker, and then in 2018, she cosponsored the Marijuana Justice Act along with Sen. Booker. In 2019, when she was running for president of the U.S., Gillibrand released a plan for the national legalization of cannabis, saying that she would make the issue a “top priority” of her presidency. “America’s federal prohibition of marijuana needs to end now,” Gillibrand wrote, acknowledging the need for access to medical cannabis. “Millions of Americans seek medical marijuana to treat chronic or severe pain — often in an effort to avoid prescription opioids — but access is limited by insurance coverage and availability of medical marijuana dispensaries, even in states where medical marijuana is legal,” Gillibrand wrote. “We should be expanding patients’ access to treatment they need, especially when it helps reduce addiction to dangerous medications.” Little action at the federal level isn’t helping anyone, and she believes supporting cannabis could be a major factor in the upcoming general election. Federal authorities have been toying with the idea of rescheduling cannabis to schedule III, and cannabis would be regulated like Tylenol III’s or hormone replacement therapy. If the HHS’ recommendation to reschedule cannabis on the federal Controlled Substances Act becomes a reality, it could make an impact on President Joe Biden’s favorability ahead of the upcoming 2024 presidential election. There is now data to support that idea. A recent survey found broad support across demographics and suggested Biden could see an 11% favorability boost if it occurs. The survey, conducted by Lake Research Partners, revealed a number of key findings surrounding registered voters and attitudes surrounding cannabis, namely that Biden could boost his favorability by 11% among younger voters should cannabis move from Schedule I to Schedule III. “By the end of the poll, impressions of Biden improve by a net double-digits—an 11-point swing overall, including a double-digit (+11-point) swing among younger voters,” the survey notes.  “In conclusion, rescheduling cannabis is not only the right move from a policy perspective, it is also politically helpful,” the survey concludes. “Nowhere is this more true than for younger voters—one of the most cross-pressured groups of voters, and also the most sanguine about rescheduling.” New York leaders like Gillibrand believe reclassifying cannabis under schedule III does not go far enough. Instead, the Biden administration should take a bolder move and deschedule it altogether, giving Americans what they clearly want.

https://hightimes.com/

Long Beach, California To Slash Pot Taxes in Half for Stores in Good Standing

Long Beach, California is on track to establish an ordinance that will give cannabis retailers a minor tax break and reward the ones in good standing on their payments with a bigger tax break, cutting their local tax in half. At a Jan. 23 meeting, Long Beach City Council members voted to request an ordinance be drafted to lower rates for businesses that meet hiring and compensation markers and are up to date with their current tax payments. City leadership has been aware about the significant tax burden impacting cannabis businesses across California. Not only in Long Beach, but California’s entire cannabis supply chain faces a chronic debt problem, and the SF Gate called it an “extinction event” last year. In one move, state law recently shifted the burden of excise taxes from distributors to retailers. Over a dozen cities and counties in the state cut taxes to assist retailers with this dilemma. The tax break fulfills a goal set on April 20, 2023, when the Long Beach City Council vowed to lower tax rates as part of the 2024 annual budget, the Signal-Tribune reported. “We should be aiming to create a positive feedback loop: reduce the tax burden on local operators, allow them to be competitive and expand their businesses, while rewarding those high road employers and operators who make investments back into our community, all while nurturing a new revenue source for the city,” said Councilmember Joni Ricks-Oddie, who brought the item forward. As of the last count available in 2023, Long Beach was home to 32 retail cannabis stores and 37 cultivators. During the Prop. 215 era, the city was home to even more medical cannabis dispensaries. Long Beach Post News reports that Tuesday’s vote advanced a cut at 1 percentage point for retailers with the opportunity to qualify for an additional 3 percentage-point drop if they meet “good standing requirements.” Cannabis cultivators would also get a similar tax break. Their square-footage tax was cut from $14.96 to $13.09, the equivalent of a 1 percentage point cut. A tax break couldn’t come sooner. The city of Long Beach currently imposes a 6% excise tax on medical cannabis transactions and 8% on recreational adult-use cannabis sales, on top of the city’s sales tax of 10.25% and the state’s excise tax of 15%. The state taxes have been imposed since adult-use cannabis use became legal in California in 2016 Long Beach adult-use cannabis sales generated $9 million tax revenue of around $13 million in cannabis tax revenue the city expected to collect in 2023. Several city council members expressed concern over the unpaid taxes, preferring to bring those payments up to date before giving businesses any kind of special tax breaks. “I do think we should have a heavy hand for those businesses that haven’t been compliant with our taxes,” Councilmember Al Austin said at Tuesday’s meeting. “The city needs that revenue.” In order to be eligible for the larger tax breaks, retailers would have to be up to date with licensing and tax payments, and they would have to meet several other requirements. They would also have to ensure that at least 40% of their staff are Long Beach residents and that they are paying their employees between 110% and 115% of the state’s minimum wage. Retailers would also have to support equity businesses by keeping their products on shelves or providing mentoring and incubation support for equity operators. If the changes are fully implemented, the tax cuts are projected to cost the city about $3 million annually.  The 1 percentage point cut for retailers across the board is expected to cost the city just over $1 million, according to data presented to the council. Many local residents complained in recent months that the equity program to support cannabis stores from low-income, justice-impacted residents has resulted in just one successful equity applicant and asked the city to do better.  Others said there’s a great opportunity in the city. Long Beach Green Room owner Adam Hijazi, for instance, said that Long Beach could cut tax rates in order to support legal cannabis businesses and create a cannabis destination in the city.  The city hopes to follow in the footsteps of other California cities like Santa Ana, in providing tax relief by prioritizing businesses that are in good standing, and the ones that give their employees more than minimum wage or provide career opportunities.  Santa Ana took a similar step and implemented a 1% tax cut for most cannabis stores in the city and an additional 2% for “high road” employers.  The council will still have to vote on the ordinance twice before the changes take effect, something that’s expected to happen in the coming months.

https://hightimes.com/

Amsterdam Mayor Advocates for Legal Cocaine Sales

The Mayor of Amsterdam wants to legalize and regulate the sale, possession and use of cocaine.  In an interview with Dutch newspaper Financieele Dagblad, Mayor Femke Halsema very strongly voiced her opinion on drug prohibition and how the decriminalization and legal sale of drugs like cocaine would take power away from organized crime groups who threaten the safety and stability of Amsterdam.  “We have handed the market to unscrupulous criminals. They earn billions. And in the meantime, the war on drugs is disrupting entire countries, causing countless victims and strengthening the criminal business model,” Mayor Halsema said.  Indeed Dutch Customs has recently released a report which supported the notion that organized crime surrounding cocaine trafficking is on the rise in Europe. Dutch Customs seized over 60,000 kilograms of cocaine in 2023 and 51,000 kilograms in 2022. Mayor Halsema has arranged a public debate on the matter which has been scheduled for January 26 in Amsterdam. Cocaine seizures around Europe have followed the same trend with hundreds of metric tonnes seized around the EU year after year. Many reports have attested that the average price of European cocaine has been cut almost in half and the UN reported in March of last year that cocaine production was at an all time high.  “Let us conclude that hundreds of years of discouragement and repression have achieved very little,” Halsema said to Financieele Dagblad. “Apparently people have a need for stimulants. There is a market for that.” Mayor Halsema has been a vocal advocate for change in the City of Amsterdam since her appointment to the role in 2018. She wrote an opinion piece for the Guardian earlier this month in which she expressed that the Netherlands risks becoming a narco-state if steps are not taken to reign in organized crime.  “The widespread use of drugs is integrated into society. The market is enormous. But there are risks to public health and then you should not leave the market to criminals,” Mayor Halsema said to Financieele Dagblad. “Abusing drugs can have serious consequences. But often the risks are exaggerated. Cocaine, for example, is less harmful than alcohol. People make their own choices.” Mayor Halsema also told Bloomberg in July of 2022 that she would be taking steps to cut back on problematic forms of tourism post-COVID. She intimated that Amsterdam needed to pull back from the reputation it has garnered as a sort of safe haven for ne’er do wells who came to her city to take a “vacation from morals.” “In Amsterdam, there’s a state of mind of tolerance. We always argue that cannabis should be legalized and prostitution shouldn’t be criminalized. That is also a part of Amsterdam’s history, a history that we’re very proud of,” Mayor Halsema said to Bloomberg. “But drug culture and prostitution have been internationally commercialized. That is not the way it was intended. We should correct the way we advertised the city in the last 15 years.” This may seem a bit disconnected for a Mayor advocating for legal cocaine sales but from a harm reduction perspective, it makes sense. Mayor Halsema likened it to Amsterdam’s famous red light district which from her perspective is there to provide safety and security to sex workers who, as she puts it, will always be there to serve customers so long as there is a demand for sex work.  The same can be said of cocaine sales. A 2023 report from the European Monitoring Centre for Drugs and Drug Addiction found that cocaine was the second most commonly abused drug in Europe next to cannabis and cocaine seizures in major seaports around the continent have consistently risen every year since 2016. A survey found that almost 2.3 million Europeans between the ages of 15 and 34 had used cocaine in the preceding year. These record increases in use and trafficking led Switzerland to recently open discussions to consider the launch of a pilot program for adult-use recreational cocaine sales in their capital city of Bern. Mayor Halsema appears to have followed suit by doubling down on what she considered to be a common sense approach to drug policy.  “What the Netherlands’ problems reveal is the need for a global shift in the current approach. It’s not a matter of retracting our user-centred policy, but rather advocating for international recognition that the war on drugs is counterproductive,” Mayor Halsema wrote to the Guardian. “The prohibition of drugs is enshrined in international treaties that limit the space for national drug policies, meaning we will have to forge new international alliances that prioritise health and safety over punitive measures.”

https://hightimes.com/

Survey Shows Broad Support for MJ Rescheduling, Boost for Biden if Accomplished

If the Department of Health & Human Services’ (HHS) recommendation to reschedule cannabis on the federal Controlled Substances Act becomes a reality, it could make an impact on President Joe Biden’s favorability ahead of the upcoming 2024 presidential election. A new survey, conducted by Lake Research Partners, revealed a number of key findings surrounding registered voters and attitudes surrounding cannabis, namely that Biden could boost his favorability by 11% among younger voters should cannabis move from Schedule I to Schedule III. To gather the data, researchers engaged 900 likely voters through phone calls and text-to-online outreach. The survey includes oversamples of younger voters and voters in presidential battleground states (100 voters aged 18-25 and 200 voters in battleground states, Arizona, Georgia, Michigan, North Carolina, Nevada, Pennsylvania and Wisconsin). The survey looked more generally at the support behind rescheduling cannabis, with 58% of participants showing support and 19% opposed. Researchers said that support also crossed most demographic lines, and no more than one-third of voters in any major subgroup was opposed to rescheduling. Young voters, those aged 18-25, showed the strongest levels of support for rescheduling at 65%, with nearly half indicating they felt strongly about the issue. Support was strong across age demographics, with seniors showing support by a double-digit margin. Democrats and independents also showed strong support (74% to 7% and 55% to 15%, respectively), while Republicans were more divided (41% to 31%) despite showing more support overall. The survey also found that younger Republicans and Republican women were disproportionately more supportive. Two-thirds (66%) of voters also said that Biden should accept the recommendation, with young voters 18-25 showing overwhelming support (84% with 77% indicating they felt strongly about their answer).  Researchers also found that attacking rescheduling didn’t sway voters, despite the fact that “no punches were pulled” in articulating the opposing viewpoints. These include the rescheduling proposal being a “half measure,” comparing cannabis regulation unfavorably to regulating alcohol, the argument that it will provide “massive profits to pharmaceutical companies” while resulting in “hundreds of thousands of Americans behind bars for marijuana-related offenses). After reviewing opposing arguments for rescheduling cannabis, 58% voters continued to support rescheduling while 18% opposed. Support among young voters remained strong, with 66% behind rescheduling including 50% with strong support. “By the end of the poll, impressions of Biden improve by a net double-digits — an 11-point swing overall, including a double-digit (+11-point) swing among younger voters,” the survey notes.  “In conclusion, rescheduling cannabis is not only the right move from a policy perspective, it is also politically helpful,” the survey concludes. “Nowhere is this more true than for younger voters—one of the most cross-pressured groups of voters, and also the most sanguine about rescheduling.” Concrete talks of rescheduling cannabis first began in Oct. 2022, when Biden made a statement asking the secretary of HHS and the attorney general to review the scheduling of cannabis under federal law. In Aug. 2023, the HHS submitted its recommendation to the DEA to reschedule cannabis from Schedule I to Schedule III.  The U.S. Food and Drug Administration (FDA) also recently said they support reclassifying cannabis as a Schedule III substance, which would make medical cannabis and the research supporting it federally legal but still heavily regulated. The DEA has final authority to schedule, reschedule or deschedule a drug under the DEA and is currently conducting its review. However, there is currently no specific timeframe on when the DEA will make its decision. Researchers also note that the findings of the survey align with a recent Gallup poll, which found that support for legal cannabis hit a record high of 70% among all adults in the U.S. Namely, they highlight that the poll found the highest levels of support in the youngest age cohort, with 78% of the 18-34 age group supporting legalization.

https://hightimes.com/

Delta 9 and Beyond: Your Guide to THC Gummies

Ready to take the plunge and enter the mind-bending world of THC gummies? It’s actually not quite as simple as that. There are different types of THC, each of which is capable of delivering a different kind of THC experience for users. So, with that in mind, we’ve created an easy-to-follow gummy guide for THC users to help you find the chew that best suits your needs.  Before we begin, let’s look at some top products in every cannabinoid category: Best Delta 9 Gummies: CBDfx Magic Melon Delta 9 Gummies, TRĒ House Peach Pear Delta 9 Gummies Best Delta 8 Gummies: TRĒ House Blue Raspberry High-Potency Delta 8 Gummies Best Delta 10 Gummies: TRĒ House Blue Raspberry Delta 10 Gummies Best THC-P Gummies: TRĒ House Tropic Mango THC-P Gummies Best HHC Gummies: TRĒ House Strawberry Burst HHC Gummies Try any of these best-selling gummies and get 25% OFF + FREE ground shipping with code TRYTHC! Let’s start our gummy guide with a quick primer on THC, itself. THC (tetrahydrocannabinol) is one of two major cannabinoids found in the cannabis plant, along with CBD. Cannabinoids are chemical compounds that the plant uses to ward off predatory insects and grazing animals, as well as protect the plant against the elements and attract pollinators.  Your body produces its own cannabinoids, called endocannabinoids, which are part of a cell-signaling system known as the endocannabinoid system. This system helps the body to maintain homeostasis (balance), which affects a variety of functions, including sleep, memory, appetite, motor control, and many more. THC and other cannabinoids interact with sensory receptors in the endocannabinoid system, producing intoxicating or psychoactive effects. That is to say, THC can get you high! While the products we’re looking at today contain THC, they’re not made from marijuana (sorry, no weed gummies). The gummies we’re spotlighting are made with a low-THC form of cannabis, called hemp. Hemp cannabis products (under 0.3% THC) were made legal at the federal level with the passing of the 2018 US Farm Bill. But that doesn’t mean the gummies in question aren’t totally party-ready, as you’ll see shortly. There are several reasons cannabis enthusiasts prefer THC gummies. First, as cannabis edibles, these gummies have longer lasting effects than THC vapes or sublingual oils. In fact, depending on the strength of your THC product and your own personal bioavailability factors (such as height, weight, and THC tolerance), you can enjoy the effects of THC edibles potentially for six to eight hours. And THC-infused gummies taste great, which is an advantage for these canna-chews over capsules. Here’s a handy chart, comparing the effects of edibles versus other types of THC products. Shopping for THC gummies seems pretty straightforward. One could easily assume delta 9 gummies are the only game in town. It’s pure THC, right? But there are several types of THC, which means there are multiple types of cannabis-infused gummies available to consumers.  Delta 9 THC is the big boi. The OG. It’s the cannabinoid one can generally expect to enjoy if a product is simply called, “THC gummies.” In the right quantities, delta 9 can deliver both euphoria, flourishes of creativity, and other uplifting effects—particularly when derived from sativa strains. Indicas lean more on a body high, with blissful relaxation. Either way, you’re in for a good time with D9 gummies. There are several quality brands in the delta 9 THC gummy market. CBDfx, a leader in the CBD industry since 2014, has created a popular line of delta 9 THC products in recent years. Among these products is a potent collection of high-quality delta 9 THC gummies. All of CBDfx’s gummies are made with organic hemp and all-natural ingredients. Each of their products (CBD and THC) is backed by a Certificate of Analysis (COA), which is a third-party lab report that verifies the amount of THC, CBD, and other cannabinoids in your gummies, as well as alerts you to the presence of any pesticides or other toxins. In short, a COA ensures the purity and potency of your product. TRĒ House is the leading brand in recreational hemp products, including THC-infused gummies, syrups, vapes, and prerolls, as well as magic mushroom products. They also use only the highest quality hemp and ingredients, making their delta 9 gummies a must for any stash. TRĒ House’s THC gummy line includes three THC-only gummies, as well as blended gummies with other cannabinoids, including CBD, HHC, and delta 10 THC. TRĒ House offers a wide selection of both delta 8 gummies and delta 10 gummies. Delta 8 and delta 10 THC are isomers of delta 9 THC and have similar effects, albeit in differing intensities. Both have a euphoric buzz that’s similar to delta 9, but a bit more mellow. Of the two, delta 8 is generally considered the more powerful. But the thing to remember is that comparing these cannabinoids mg to mg isn’t always apples to apples when you’re looking at gummy products. A high-potency delta 8 product, like TRĒ House Blue Raspberry Delta 8 Gummies, can have so much D8 content that its effects are comparable to a proper delta 9 product. Like deltas 8 and 10, THC-P is a minor cannabinoid, meaning it only occurs in tiny amounts in cannabis. But THC-P’s effects are massive. It’s estimated that THC-P is 30 times more powerful than delta 9! So, you’ll understand if the milligrams on a THC-P product are comparably low. But rest assured, you’ll get baked as a cobbler. HHC is created by adding hydrogen molecules to delta 9. The result is a gentler THC, making it a great choice for mellow moods. Both make great additions to any stash, particularly if you like a little variety in your seshes. Unsurprisingly, TRĒ House is the place to go for these less common cannabinoids. Their Tropic Mango THC-P Gummies combine THC-P with delta 8 and HHC, giving you a well-balanced head and body vibe. On the HHC side, TRĒ House offers a couple of blended HHC gummies, as well as a potent HHC-only offering. No matter which gummies you choose, always insist on products made with organic hemp and natural ingredients. And make sure to shop with established brands, like CBDfx and TRĒ House, that provide a Certificate of Analysis to ensure you’re getting a pure and potent product every time. It also helps to shop for THC and CBD products from a retailer that understands the importance of carrying quality brands like these, such as CBD.co. At CBD.co, you’ll find a wide range of trusted brands and high-quality products. We hope your THC adventure is a safe and enjoyable one!

https://hightimes.com/

Kansas Advocate Groups Call for Medical Cannabis Legalization

Representatives from the Kansas Cannabis Coalition, Loud Light, and the ACLU of Kansas held an online meeting on Jan. 23 to discuss why they need to call on the Kansas House and Senate to move forward with medical cannabis. Initially, the day was intended to be a “day of action at the Capitol” in Topeka, Kansas, according to the Kansas Reflector, but due to unsafe weather conditions, the meeting was shifted to be held online instead. During the meeting, some people spoke about how they or people they love have found relief in cannabis. Advocate Delaney Jones explained that his grandmother, who survived European concentration camps in World War II, suffered from late detection of pancreatic cancer. She was in intense pain and suffered from the side effects of opioids and chemotherapy, but finally found relief with cannabis oil. “It helped her get rid of the pain and the nausea, even the fatigue at times,” Jones explained. It did not have the side effects of opiate painkillers. We were super, super grateful to see really the magical work that marijuana did in her end-of-life care.” Kansas Cannabis Coalition President Cheryl Kumberg said that five years ago she was assured by legislators that it would take one to two years to put together a medical cannabis bill. I’m here in open-mouth amazement that we are still discussing passing a medical marijuana bill,” said Kumberg. “It is just the same excuses all these years. The same rhetoric from opponents and legislators. We’re just like this little island.” Due to the delay, cities in Kansas have created ordinances to decriminalize cannabis, but statewide legalization is long overdue. “We’ll just have this sort of understanding or unwritten rules and laws that we won’t prosecute cannabis,” said Kansans for Hemp and Kansas Cannabis Coalition member, Kelly Rippel. “It leads to inconsistency around enforcement, not only in communities, but also the district attorneys in counties. We need to have something on the books that says, ‘We are not going to criminalize this, especially for personal possession.’” Rippel added that legislators also need to focus on expunging cannabis-related convictions and record sealing. As an example, Latanya Goodloe, Ladies That Lean executive director based out of Kansas City, Kansas, shared that she served four years in prison for possession and intent to sell. Although she completed her parole in 2009, she ran into challenges for having the felony on her record. Goodloe also believes that the conversation of legalization needs to be accompanied by law that rights the wrongs of the War on Drugs and pursues racial and economic justice. “No monopoly,” Goodloe explained. “Engaging the public, sustainable regulations are key components to shaping a system that addresses both health concerns and economic considerations. At this point, we have no reason to not put marijuana on the table.” ACLU of Kansas legal director Sharon Brett mentioned the parallels between legislator opposition of medical cannabis as well as abortion, citing the similarities of the government attempting to control citizens’ healthcare opportunities. In August 2022, voters rejected a measure that would have amended the Kansas Constitution to state that “the constitution of the state of Kansas does not require government funding of abortion and does not create or secure a right to abortion.” The measure did not pass with 58.97% of voters voting no, and 41.03% voting yes. “Refusal of the Legislature to legalize medical marijuana is the Legislature essentially inserting itself into medical decisions that should be made between a patient and their doctor,” said Brett. “This policy choice is about liberty and autonomy. It is about who is getting to decide important medical decisions—you and your doctors or politicians in Topeka.” Considering that 38 U.S. states, alongside Washington, D.C., and the U.S. territories of the Northern Mariana Islands, Puerto Rico, and Guam, have legalized medical cannabis, advocates feel it is well past time for Kansas to follow suit. In recent history, the Kansas House proposed a medical cannabis bill in March 2021, but it died in committee by May 2021. In March 2023, the Senate Federal and State Affairs Committee shelved a bill that would have legalized medical cannabis, with the chairman saying that they have more important matters to attend to. Gov. Laura Kelly responded to the shelved cannabis bill, calling on the committee to reconsider the bill and take action in the 2023 legislative session. “I am disappointed that some legislators are saying they don’t want to move forward with legalizing medical marijuana this year—effectively turning their backs on our veterans and those with chronic pain and seizure disorders,” Kelly wrote on X in March 2023. “If they get their way, for yet another year thousands of Kansans will be forced to choose between breaking the law and living without pain. I encourage Kansans to call their state legislators and tell them to legalize medical marijuana this session.” To date, no medical cannabis bills have ever made it far enough to land on a governor’s desk in Kansas. Previous Kansas governors, such as Mike Huckabee, weren’t as supportive as Kelly when it comes to cannabis. In October 2022, Huckabee released videos that made claims about adult-use cannabis only benefitting drug cartels and other inaccurate statements. “Unfortunately, you aren’t the one who is going to be making the money, drug cartels will,” Huckabee claimed. “And if you are one of those people that can sell the drug, maybe you’ll make a buck off of the gullible people who will somehow convince themselves this is absolutely harmless.” Poll results published by Fort Hays State University in October 2023 show that two out of every three Kansans support cannabis legalization, with a fairly balanced split between Republicans (75%), Democrats (73%), and Independents (60%). Many participants also said that they would vote for legislators who share support for medical cannabis legalization in particular.

https://hightimes.com/

The Winners of the High Times Cannabis Cup Oregon: People’s Choice Edition 2023

The long-awaited High Times Cannabis Cup Oregon: People’s Choice Edition 2023 results are finally here! It’s been eight months since we announced our return to explore the Beaver State, and the wait has finally ended. It’s an especially unique return too, given that technically we haven’t been back to check out Oregon’s plethora of offerings since our People’s Choice Edition cup was announced in July 2020, and results were published in January 2021. That all being said, a lot has changed since our last in-person cannabis cup event in Oregon, which was held in 2019 (remember the pandemic? It feels like a fever dream now). Back then, we were seeing popular strains Ice Cream Cake, Sundae Driver, Ghost Train Haze, Forbidden Fruit in the winner’s list. Concentrates included a handful of gorgeous diamonds, live resin sauce, sugar, and so much more. (And for edibles lovers, who can forget marshmallow bon-bons, infused lemonade, and fudge.) Then the 2020 Oregon People’s Choice Edition results showed in early 2021. We had to shift some of our planned dates due to devastating wildfires that ravaged the area at the time, but crowd favorite winners were strains such as Strawberry Guava, MAC1, Motorbreath, Blueberry Muffins, and Mimosa that took home awards. Brands like Deschutes Growery, PDX Organics, and Decibel Farms took home multiple awards in categories for flower, while concentrate trends included delicious live rosin and solventless hash rosin. Our edibles category expanded that year, so there were many more crowd favorite chocolates, caramels, gummies, brownies, and cookies. It’s been nearly two years since we’ve asked the good people of Oregon to meticulously rank some of their state’s best products. Now check out the new generation of winners, from returning fan favorites to brand new competitors that seriously impressed our judges. First Place: Culture Farms x Backpack Boyz – Lemon Cherry Roze Second Place: Green Clover Farms – Sour Pistachio Third Place: Eastwood Gardens – Runtz Horchata First Place: Pruf Cultivar – Jack Herer Second Place: Trichome Farms – Black Widow Third Place: Eastwood Gardens – Lemon Royale First Place: Earl Baker – Super Buff Cherry Second Place: Pruf Cultivar – Blue Apricot Sherbet Third Place: Culture Farms – Watermelon Gelato First Place: Trichome Farms – Forbidden Fruit Gelato Pre-roll Second Place: Decibel Farms – Apple Slapz #3 Pre-Roll Third Place: Lit Sticks by PDX Organix – Orange Julius Pre-Roll First Place: Portland Heights – 1G Moonrock Slims Blue Lambo Infused Pre-Roll Second Place: Shadowbox Farms – Douggie Infused Blunt Third Place: Casbah Hash – Hashish Infused Joint First Place: Capital Cannabis – Guava Pie Live Batter Second Place: Dr. Jolly’s x 54 Green Acres – Green Dragon Live Resin Third Place: NW Kind – Lemon Meringue Diamonds & Sauce First Place: Bonsai Farms – Cherry Pie x GG4 Live Rosin Second Place: Cascade Valley Cannabis – Apples & Bananas Live Rosin Third Place: Decibel Dabs – Citrus Palisade #2 Live Rosin First Place: Dr. Jolly’s x Sol Cultivations – Orange Cream Live Resin Vape Second Place: Calyx Crafts – Fat Burger Live Resin Liquid Diamonds All-in-One Vape Third Place: Buddies – Mt Hood Magic Liquid Diamonds Buddies Pod System First Place: Smokiez – Sour Watermelon Fruit Chews Second Place: Electric Lettuce – Summer Edition Cosmic Pop Gummies Third Place: Nelson & Co. Organics – Strawberry Carefree Jellies First Place: Yamba Floss – Blueberry & Strawberry Cotton Candy Second Place: Hapy Kitchen – Toffee Crunch Blondie Third Place: Quality Drugs – Fall Edition Variety Pack Cannabis Infused Caramels First Place: High Desert Pure – Fast-Acting Mango Nano Chill Elixir Second Place: Fruit Lust Flavorz – Strawberry Nano Tech Syrup Third Place: Peak – Rescue Rub 2023 was a huge year for the High Times Cannabis Cup: People’s Choice Edition. In total, we celebrated the results of six competitions in Michigan, SoCal, Illinois, New Mexico, in addition to Oregon, as well as our annual Hemp Cup. That’s just the beginning. 2024 is looking to be a great year as well with our Massachusetts and Arizona People’s Choice Edition competitions well underway. Plus, we have a few more cups announcements soon to come, so keep an eye out for more news in the near future. A special thank you to our partners and sponsors!

https://hightimes.com/

Keeping it 10

If you’ve been paying attention to the top-shelf landscape over the past few years, it seems the largest problem plaguing our industry today is consistency. Sure, you can pop off a new cultivar and make some noise for a little while, but maintaining the pressure is difficult, and very few players have managed to stay on top for even a season, let alone a full year. You need to have all your t’s crossed, and your i’s dotted, all the time. While there are more competitors joining the game every day, none can touch the bar that The Ten Co. keeps pushing higher. The Ten Co.—formerly Team 10 Extracts and the purveyors of the hyper-viral Zushi brand— have proven that maintaining relevance in this space isn’t impossible, it just takes hard work. And, given the tear Ten’s been on, the rest of the market should be taking notes. While both The Ten Co. and Zushi brands have been increasing in popularity and notoriety over the past few years, thanks primarily to the strength of Staks’s cultivar curation, in 2023 the brand exploded to a new height not just for themselves, but for the industry. Hosting two of arguably the biggest brand activations our culture has seen, in two of the biggest markets in America (New York City and Los Angeles), the brand has amassed such a demand that they’re now able to pop in to your city and make more money selling merch than most are able to selling their top shelf. Before we get into the details of what they’re doing, and where they’re headed, let’s go back to the beginning. Founded by Staks in 2011 (or ’12), Team Ten’s origin began far from California, all the way across the pond in Europe. A British-born Cypriot raised in a musical household in London, Staks was exposed to the ins and outs of the counterculture from a young age, thanks to his adjacency to the entertainment industry. “I’ve been in love with cannabis since I was probably 11 years old,” Staks explains. “Around 15 I set up an LED light in my boiler room cupboard. Mom found out and went crazy on me.” Through the time he spent writing music when he was young, he unintentionally honed an understanding of how the cannabis market worked, and developed a vast network of relationships with celebrities. “I had a huge passion for hash. Making isolate or bubble hash… I used to go to Amsterdam regularly—like every two to three weeks—and got involved in different techniques of hash production,” Staks says. “I was obviously very limited in London at the time, so that’s when I decided to move to Spain, back in 2012. This was when the BHO market was booming, we were really the first to bring that to the market. We were Team 10 Extracts back then.” He glazed over an important milestone there, before moving to Spain, Team 10 Extracts was officially founded, and had already begun winning awards. They are cited as hosting the first-ever infused dinner party in the U.K. Earning his first recognition before he left his home court, in total, the brand had received over two dozen accolades before the eventual move to the U.S., but we’ll get there. “The technique was the secret,” he says. “Once the technique was dialed in, we didn’t really think about branding that heavily back then. In Europe it’s more about the quality of the product rather than the brand, even to this day you’ll see the best weed unpackaged, unbranded. They don’t care about the bag and stuff, they want to see the product.” Gaining notoriety now, Staks eventually began to enter Team 10 Extracts into some of the largest competitions in the world. Eventually, in 2015 he signed up for the Secret Cup, which held events around the world as qualifiers, and then held a world-wide grand finale in California. “I entered this competition, against people who… were like idols to me because being from overseas I could only see these guys online… and we came in first place. It was mind-blowing to me. It was the Headbanger by Karma, still one of our favorites to this day,” he says proudly. “I always considered myself a connoisseur in the space, so this was very validating to me, but winning this competition got us placed in the finals in Los Angeles the next year. That was my first time coming over to the states.” This was around the end of 2015/start of 2016. “I flew out here and that was the first time I met Cali Kush Farms, through Karma, and they were kind enough to let me have some of their space to make some fire,” Staks says. “This was another huge, huge competition at the time. There was great names, great product in the competition. I thought I had no chance. And then we placed. We came in third place in LA. And I just remember my IG growing by like 20,000 in a week or two. I had made my mind up, I [was] moving to America to chase my dream.” In 2017 Staks officially moved to America, just in time for the rise of rosin and the crash of the BHO market. Recognizing the shifting landscape, Staks decided to shift things around in his new home. He dropped the “extract” from his brand’s name, and The Ten Co. became the core focus, a high-end flower brand that would allow him to focus on his first love. Shortly after he aligned with Gerry, a creative director originally from San Jose, and created what would become the foundations of Zushi. “Zushi is like a strain brand,” he says. “I made the logo myself, and I don’t consider myself a designer in any way. Prior to meeting Gerry my whole goal was to find the dopest guy in the game that can make the product sick… and the way we met, it was just crazy.” While Staks operates the flower side of the business, things took a, let’s call it “branded” turn, once he met Gerry. With a long history of creative expression and development, including a stint with the internationally celebrated World Star Hip Hop, Gerry has become something of the secret weapon in Ten’s arsenal. Before we get into his specific contributions to the company, here’s a bit more background on who he is. “I fell in love with design when I was young. At 5 years old I started drawing art and just always kept with it. Fast forward to when I was about 18 or 19, my uncle asked me to draw a T-shirt…” Gerry tells me. “I didn’t even know what vectoring was at the time, so I just went to Google and started looking. I found out about digital art, and through that I felt like, ‘Oh shit, I could actually spread art to the masses rather than just have one piece.’ So I took myself to YouTube school, and I learned all the software by myself… Illustrator first, then Photoshop, and just kind of combined the two. “I was posting on Instagram, and at the time I was big in the sneaker community. We would take pictures from our knees down, and I started doing that with cool captions that matched with like Jordans or Nikes. I started posting time lapses of my art, and then I got picked up by Worldstar Hip Hop. Q, the owner of Worldstar, found me before there was even DM’s. He wrote like on the comment ‘Yo email me at Q@worldstar and delete this right after.’” The relationship with Q opened a lot of doors for Gerry, and things took off quickly from there. Eventually, in 2019, a favor for a friend led to a fateful meeting. “My friends were selling this record, a Lil Baby and Gunna track…” Gerry says. “I met up with this person to actually get paid out for the tracks, and it was Staks. And he mentioned like, ‘Oh, I have Zushi, and I heard you’re a designer. We should link up and see what we can do.’ I just thought that the name was cool, and a million ideas started coming. “At the time I think I had seen what was already done, and I just tried to 2.0 it and not really give my take on what I would visually do. But when we rebranded the font… that was like the first thing I had on my iPad when we linked up again.” Staks notes that they both collect KAWS and Takashi Murakami who were big inspirations. “The bright colors, the vibrance. This cool, hip [look], no one had that in the space at that time, so we just started dialing characters and they just started coming to life,” Gerry says. “Blue was born first, and at first he looked way too cartoon-y. We’d both give feedback and we would be up until like two, three in the morning every night for like months. After a while we just started getting into a flow.” That flow created a cultural tsunami. “Being a part of hypebeast culture ourselves, we know what that can do once you attach the branding and the marketing with the great product. That’s what creates the whirlwind of greatness, you know?” Staks explains. “Gerry is a unique character, you know. Guys like him ain’t really that easy to come by. To lock in, and have full concentration on that project. That’s what he showed me, his loyalty to the brand, from the beginning, where he was turning down other work and we were just executing every single idea to a T.” Today the brand has five distinct characters within the Zushi-verse: Blue, Yellow, and Pink Zushi, Wasabi, and Zoy. Each has dedicated product lines, but also a seemingly endless merchandising potential. This potential is probably best visualized by the success of their Nozu launch. Comprised of the best batches they cultivate from each of their strains—the choice packs, if you will—The Ten Co. recently introduced the Nozu line, named in homage to Nobu, the popular high-end restaurant they frequent. “At the time we were getting specific batches that would come around and they would just stand out,” Staks says. Now while people would be lining up for access to the most premium packs a premium brand offers to begin with, the Nozu line came with a lot of bells and whistles. While by this point people had been dropping branded boxes with their products, they rarely went further than pretty cardboard and maybe a grinder. The first drop of Nozu arrived in the form of what looked like a to-go champagne bag from Nobu. It obviously didn’t have a bottle of champagne, but a Miron glass jar filled with an ounce of their highest end flower, as well as branded napkins, chopsticks, and a rolling sushi mat. It even had a Nozu receipt, and it commanded a $1,000 price tag. Next they released a surf and turf collectors box with packaging that looked like lobster tails and steaks, and a jar of “truffle butter” rosin. Most recently they’ve taken Nozu on the road, and held merch pop-ups in both the New York and Los Angeles Zalympix events. “With Nozu—well with everything, but specifically Nozu—it was bigger than just throwing in some cute extras,” Gerry says. “We’re creating ecosystems within the brands. We’re building worlds, lifestyles. It’s deeper than just unique packaging. We brought in sushi rolling chefs…It’s been in the works for I would say like two years. We had to perfect it just how Staks perfects the flower, the same thing had to go for the apparel. Printing those characters is super difficult. There’s tons and tons of colors. We must have tried like five different manufacturers. It just wasn’t it, and then recently we finally felt like, ‘OK, now it’s time.’” “We’re creating a storyline, and it’s started coming to life,” Staks says. This demand is probably best expressed by their first Blue Zushi rosin launch, which included just 76 jars, and saw a market that was willing to pay $500 a gram. So willing, in fact, that it was nearly impossible to find, and I’ve seen people taking their jars around the world, popping up online from Japan to Barcelona, despite it being released in Los Angeles. “We’ve been talking about dropping Zushi rosin like, forever, and just never got around to it. I think the anticipation made it special,” Staks says. “Massive thanks to West Coast Alchemy, they did a great job. Thanks to Bobby Trill, that’s my homie.” Today the future’s bright for the entire Ten enterprise. With a new solventless line coming, along with the debut of their 10Pen, a proprietary vape they have been developing, the brand is actively pursuing new business areas, while doubling down on what they do best. Not only that, but for all those who missed the pop-ups, a worldwide merchandise release will be dropping online in time for the holiday season. “Everything is pretty much under one roof at the moment,” Staks says. “We don’t really have any partners. I have the team now, pretty much built from the moment I got here, so everything’s in house, single source. We just ran a 200-, 250-seed hunt of seeds I’ve been collecting over the last maybe 10-15 years that I brought over with me from Europe. We’ve just got those in rotation now, so we’ll be going through selection [soon].” If their past is any indicator, this wave won’t break anytime soon. It hasn’t even hit its crest yet. This article was originally published in the December 2023 issue of High Times Magazine.

https://hightimes.com/

Cosmic Potency

Wendy Baker, founder of Space Gem, celebrated a decade of making edibles in 2023—a monumental achievement that stems from a lifetime of appreciation for cannabis culture, and a commitment to working exclusively with Humboldt County ice water hash. Her products have won multiple awards at cannabis competitions, including the Humboldt County Cup and the High Times Central Valley Cannabis Cup, but most recently took home two first place trophies at the 19th annual Emerald Cup in May 2023. From Spacedrops gummies to Mind Expanding Belts, Gem Guice beverage enhancer, and Cosmic Tincture, Baker has put her edibles out into the universe, designed to uplift and inspire. The edibles only use organic coloring and flavors, are free of chemicals or solvents, and are made in Humboldt County, California. Baker grew up in Chicago, Illinois, but moved to Humboldt County when she was 21, drawn to the region’s rich cannabis culture and lifestyle. Initially she worked as an indoor cultivator but decided to enter the edibles market in 2013. “You know, I saw the market changing for growers and, being a woman selling weed, I wanted to create a product,” Baker says. “I love edibles and I went to all these candy classes and I learned how to make candy.” Baker knew that she wanted to showcase the exceptional quality of Humboldt-grown cannabis in an edible that is both delicious and also made with ingredients she could stand behind. Originally she used butane hash oil (BHO) to make Space Gem products but decided that ice water hash made the most sense. “I don’t know about those chemicals [in BHO]. And I don’t want that on my conscience at all. I just felt better if I just used ice water hash,” she says. Making BHO requires using a chemical solvent, in this case butane, to strip the cannabinoids and terpenes from plant matter. In order to prevent chemicals from lingering in the extract, the BHO must be purged in order to remove traces of the solvent. Ice water hash, on the other hand, is a solventless method of extraction that uses only ice, water, and cannabis. The cannabis plant matter is mixed with ice and water, which freezes the trichome heads, making them more brittle and allowing them to more easily detach or break off into the water. After being gently stirred and sifted through numerous bags with varying sizes of small holes (measured in microns), the final product is full-spectrum ice water hash. While there are many other different methods of both solvent and solventless extraction, Baker prefers ice water hash for the best effects. “I feel like the different high, there’s like so many levels to it,” she explains. “And you’re getting like the full cannabinoid profile of the flower and you’re working with that, rather than stripping the plant of just what you need, you know?” She’s also proud to use ice water hash made from Humboldt County-grown cannabis. “Our hash comes from Humboldt,” Baker says. “I like to work with people who grow really good flower. And it all has to be processed here in Humboldt, too, because we have a Humboldt sticker on our product. So all of our products have to be made here in Humboldt and come from Humboldt.” Space Gem’s gummies, called Spacedrops, contain a collection of 10 gummies nestled together in a tin package and contain a random assortment of the brand’s 23 rotating flavors. The gummies are offered separately as sweet or sour varieties (10 mg THC per gummy), and also a CBD variety (5 mg CBD and 5 mg THC). They’re all made with organic food coloring, but the flavors in each tin vary widely—no two tins contain exactly the same assortment. Baker shares that she is particularly fond of the fig flavor but ultimately loves all of the fruity tastes she’s developed. “It’s a rainbow of deliciousness in your mouth,” she says. “And, you know, I just couldn’t pick. I can’t pick. I love them all. I love fruit. And I just thought like, if I just do the same thing over and over again, that’s so boring.” In addition to Spacedrops, Space Gem also offers a single-flavor Mind Expanding Belts, available in sour apple, sour watermelon, sweet sleepy fig, and sweet wildberry. Space Gem’s Gem Guice is a beverage enhancer that contains 100 mg of THC per bottle and comes in either grape or passion fruit flavors. The brand’s Cosmic Tincture contains of 600 mg THC per bottle and comes in blackberry, strawberry, and mango. On the back of each Spacedrops tin is the brief, uplifting message: “May cause miracles.” Each package also includes an inspirational quote on the inside of the lid. Baker explains that she and her team put a lot of effort and time into finding inspiring quotes—which come from a variety of famous people such as Dr. Seuss, author Matshona Dhliwayo, and musician Pharrell Williams—with the intention of brightening someone’s day. “You can make an impact on people, you know?” Baker says. “Sometimes the tiniest things can make someone smile or change their thoughts.” Reflecting on 10 years of success, Baker is proud and grateful for what she’s accomplished and how Space Gem has impacted people across California. “It’s pretty amazing how we grow up, and sometimes we just don’t think we’re good at anything. But I always was like, ‘Man, I’m good at this,’” Baker says. “You know? Self-confidence, believing in yourself, and just trying to make a difference, try to be an inspiration. People come up to me, you know, women, they’re like, ‘You are just picking up as a woman in the [cannabis] space.’ I’m so grateful to hear that because I want to inspire other people to be able to live what they want, [and achieve] their dreams, and their full potential.” This article was originally published in the December 2023 issue of High Times Magazine.

https://hightimes.com/

Bad Positioning: Failing from the Start

I’ve said numerous times across my articles and features here that the strength of your flower is the most important factor to succeeding in this industry, and while I still believe that to be true, it seems that some people have taken that to mean it’s the only thing that matters. I feel the need to clarify.  In today’s marketplace, while the strength of your flower will likely determine the size of your long-term customer base – that is, consumers who actually want to smoke your products regularly – 9 times out of 10 what’s actually making the initial sale for you is your brand’s marketing. It’s true that some brands are able to create that allure using only colored jars and stickers, but for the vast majority of the playing field that isn’t enough. What works in the trap doesn’t work in the shop, as they say. And it certainly doesn’t work for everyone. Now, I know everyone’s mad at the mylar wave, and no one is stoked about re-rocking the same old gear as something new and fresh, but the truth is, customers generally respond to newness, and they tend to like to buy the most sexy or flashy thing they can afford. That’s why those guys are doing it. But with all the opportunity before us today I think it’s foolish not to play the game in as big of a way as possible, and leaving out a detail  – like the way your product is displayed to potential buyers – is just no longer acceptable.  When we talk about the details that are being expressed to your potential consumers, it’s important to remember that this goes beyond just how your jar (or mylar) looks. It’s how you present the brand; how you talk about it, and how it makes them feel, are two big things they will remember. If it looks like everything else and there’s nothing discernibly special about it, especially in most of today’s chaotic retail environments, how are they supposed to choose yours versus the next guy? Let alone pay more for it… Often more important than look alone is how you’re positioning yourself. This can make all the difference in building the hype that drives a lot of this country’s major markets, and it’s often a major factor in determining how you want your actual branding to look. That’s why so many people are pushing the exclusive, or small batch thing right now. The harder it is get, presumably the more people who will be interested, and seemingly the less they have to try and *sell themselves* – but are they stopping to ask who is going to buy this high-end, low-effort project of theirs? Where you’re seen, and how, can make a big impact on your brand’s perceived quality. And it can often work against you. When I wrote Invisible Armies last fall, I highlighted what I consider to be some of the ideal consumers to target when positioning your brand, but perhaps I didn’t explain enough how different these audiences might be, and how what works positively for one may work against another. In an effort to help course correct and encourage some more thoughtful campaigns from those in our space, below are a few examples that, in my opinion, show how a marketing or positioning misstep tanked a brand’s chances for success before it even hit the streets. Hopefully learning the lessons that have cost others dearly will stop some of us from making them ourselves. You all know the definition of insanity, right? I think this is a good place to start. I’ve tried to write this as its own piece a few times, but I don’t write slams and I can’t help feeling like I’m dissing some good people in the process with this one, so let’s distill it down here instead. I want to say up front that I think many of the people that work at Monogram and the Parent Company are excellent people, and this isn’t most of their fault – it probably seemed like a sure thing, and I understand the desire to make an impact, but this one was a costly blunder.  We all remember the “Jay-Z’s getting into weed” story. He’s without question one of the greatest rappers-turned-businessmen of all time, I don’t think anyone’s contesting that, so undoubtedly it made a splash. But what does he know about weed, right? He doesn’t rap about it, we don’t ever see him smoking, surely he’s not a cultivator… so when the announcement came down that Jay-Z was starting a cannabis brand it was widely met with skepticism over adoption.  They probably thought they were launching another Ace of Spades. The packaging was gorgeous, the pricing was high, it was catered to the elite, but let’s think about this fundamentally for a second – to a real smoker, if Jay’s not a massive stoner, or cultivator, why do I want his weed? And if smokers don’t want it, why would someone who may actually understand the value of something high-end? Well here’s the part of the story you didn’t hear: Jay-Z was a face for this, and obviously part of the brains in the operation, but he was empowering real lifers. Their Head of Product, DeAndre Watson, has been in the game for years, and got to take advantage of a life-changing opportunity to partner with one of the largest music enterprises and entrepreneurs in the world to create something for himself, and the culture.  Now let me ask you, if the pitch had been “Jay-Z, the larger-than-life music mogul and entrepreneur, is empowering another black entrepreneur to create something out of the ashes of the War on Drugs that harmed so many communities and to take advantage of the multi-billion dollar opportunity now in front of him,” how differently would you have responded? I get that’s a mouthful, but it’s a vastly different story, isn’t it? One that suddenly you want to support. None of the details changed, but the way they were presented just *feels* better, no?  That’s the importance of positioning. How about something still fresh in everyone’s memory. We all saw this one. Snoop’s “giving up smoke”. Although generating many millions of eyeballs and capturing fans attention across the globe, those who have been around the block a few times instantly saw this for what it was: a marketing stunt. Many of us in the industry expected him to launch an edibles brand, or maybe a vape co if you were taking ‘smoke’ hyper-literally. I don’t think any of us expected it to be a fire pit.  Now let’s break this down. When Snoop talks about ‘giving up smoke’, absolutely no one expects him to be talking about second-hand from a fireplace. They expect him to be talking about weed. I mean no disrespect to the Doggfather with this, but in my best Kanye voice, WTF does Snoop know about fireplaces? This would have worked better as an actual air filter than it does as something virtually no one associates him with. By now the press has extensively covered the fact that the CEO of Solo Stove has been let go after this stunt didn’t perform the way the company had anticipated. Although surely getting the brand in front of tens of millions of potential consumers across the world, I wouldn’t say they left a great taste in most viewers mouths with that one. Plenty of notable people made themselves look foolish by jumping on the bandwagon of his ‘health concern’ before the full story had dropped, and I doubt any of them bought a fireplace, or talked any further about it, for that matter. So how did this help the company? Besides generating a ton of spray & pray impressions, it probably didn’t much. But it did cost them a ton of money to reach a largely different consumer than they were intending to. That doesn’t do much for the bottom line. Finally, we have probably the most common misstep I see across this industry, and that’s positioning yourself away from who you actually are. This presents itself in a ton of ways, like the new guys who act like they’re OG’s, Chads who are acting like gangsters, or the brands nobody has ever heard of who pretend they’re elite small batch cultivators because they’ve only got a few lights. We’ve seen appropriated cultural cornerstones and “master growers” who have never smoked. Often. I don’t want to specifically name check anyone with this one, but I’m sure we can all think of 2 or 3 brands immediately who use a term like “legacy brand” that’s definitely not, or who is trying to sell their work for insane rates because they just don’t produce very much of it, and not because it’s incredible. When you’re positioning yourself, understanding the audience you’re communicating with matters. One of the easiest ways to shoot yourself in the foot is to try and communicate something to one audience that it doesn’t understand, or that it rejects. For example, even talking about ounces that sell for over $1,000 is something a solid chunk of the market will outright disbelieve – which I don’t think they’re entirely wrong about but that’s a different story. The point is, your “selling points” can work against you if they’re not landing in the right spots. There’s a small percentage of smokers who want that unobtainable, and are willing to spend monumentally for it. Pitching something at those rates might appeal to them, but it’s going to price you out of a lot of the market. Do you want to look cool, or do you want to be a successful business? Or how about presenting like you’re some urban street brand on the rec market, while being run in a boardroom by ivy-league educated white guys with collared shirts? Respectfully, who do you think you’re talking to? It’s okay to make a brand for people like you: new consumers who are excited about the access and the less shady experience an Apple Store-esque dispensary provides. But do you really think you’re fooling the guys who have been here for decades? And even if you do initially, do you think they’ll come back for boof? Certainly not. But if you were targeting a consumer who didn’t actually know what was up, one you could develop, and grow with, I’m sure you’d have better results. Because not everyone is educated on the plant yet, and it’s okay to dip your feet in. You don’t have to pretend you’re something you’re not. I promise you it’s going to be easier to try and sell to yourself than it is some fictional character you’ve created in your head – you just know them better! Having said all that, I’m going to point out once more that while your pretty bag and good marketing campaign can and will make a sale, that doesn’t mean you can just put some bullshit into a bag and expect brand longevity – or any type of customer loyalty for that matter. Your actual product, and it’s effect, is what will bring a consumer back time after time. Marketing is a sales tool; it’s not a replacement for good product, but it’s also not an unimportant detail.  We’re living in a new world where soon weed’s going to be on the shelves of stores like 7-11. When you’ve gotta play against the big dogs, do you think you’ll stack up? Perhaps a better question is, have you ever seen the real titans of industry let up? Even the brands known across the globe spend handsomely on advertising annually to maintain their positions. What makes you think you’re any different? It’s not just having the best product, it’s having the best product *actually* in the people’s hands. There’s already a lot of options, and we’re just getting going. How are you going to make them choose you?  It starts with a solid foundation. 

https://hightimes.com/

New York Regulators To Vote on Proposed Weed Home Cultivation Rules

New York State cannabis regulators are set to vote on proposed rules to govern home marijuana cultivation. If the draft regulations are approved, New Yorkers will be permitted to grow up to 12 cannabis plants at home, subject to some conditions and limitations. The  New York Cannabis Control Board was initially scheduled to vote on adopting the proposed home weed cultivation rules at a meeting scheduled for Wednesday, January 25. However, the board postponed the meeting earlier this week and will instead take up the matter at a meeting next month. Once the board gives its approval, the draft language will undergo a 60-day public comment period before they are finalized. New York legislators legalized recreational cannabis with the passage of the Marihuana Regulation and Tax Act (MRTA) in 2021. The legislation approved home cannabis cultivation by adults, but enacting those provisions was delayed while the Office of Cannabis Management drafted regulations to govern home growing. Under the proposed home cultivation rules, New Yorkers aged 21 and older will be permitted to grow up to twelve cannabis plants, including six immature plants. The rules also allow for up to six mature plants, which the regulations define as plants showing visible flowers.  Plants must be grown in a secure spot out of public view and inaccessible to those under 21. Adults are only permitted to grow at a single address, with the rules forbidding multiple cultivation sites operated by the same individual. Amateur pot growers will be able to obtain cannabis seeds from any source. Weed plants, however, will only be legally available for sale in New York from cannabis retailers with nursery licenses. Home growers will be allowed to possess up to five pounds of trimmed weed from their plants, a hefty increase in the normal three-ounce limit on pot possession in New York. Cultivators are permitted to gift cannabis to other adults, but unlicensed sales of marijuana are prohibited by state law. Under the draft home cultivation rules, property owners and co-op boards are not allowed to prohibit the possession or home cultivation of cannabis. They may, however, adopt rules that require odor mitigation measures to be put in place by home growers. Not all New Yorkers will gain the right to grow cannabis at home, however. Home cultivation will not be permitted for residents of buildings operated by the New York City Housing Authority and other federally subsidized housing because of the continued illegality of marijuana at the federal level. The coming rules for home weed cultivation in New York were applauded by groups including the National Organization for the Reform of Marijuana Laws (NORML). “Adults should have the legal option to home-cultivate their own cannabis as an alternative to purchasing it from licensed retail producers,” the cannabis policy reform group wrote in a statement on Thursday. “This option is especially important for those who may not be able to consistently afford retail cannabis products, or who do not reside in close proximity to these outlets. State regulations governing the alcohol market permit adults the option to legally brew non-commercial quantities of their own alcohol, and it is consistent with this policy to similarly permit home cultivation.” The home cultivation rules will give those frustrated with the slow pace of licensed dispensary openings a way to grow their own weed. Although the state’s first regulated pot shop opened in the closing days of 2022, a total of only 53 licensed retailers have opened statewide, including 23 in the Big Apple, according to the New York Post. Melissa Moore, of the Drug Policy Alliance, said the upcoming vote on the rules is a positive development for New Yorkers. “It would just mean that people don’t necessarily have to go through consumer experience where they’re trying to find a dispensary, which has been quite a challenge as the state has been grappling with multiple lawsuits that have really delayed the rollout,” Moore said in a statement to Fox 5 television news.

https://hightimes.com/

Study: Microdosing Psilocybin May Help Treat Compulsive Behaviors, Anhedonia

Microdosing, a once somewhat niche practice, is slowly gaining momentum in the mainstream as the psychedelic renaissance continues to take shape. It’s often associated with psychedelics like LSD and psilocybin, involving a regular dose of very small amounts of a substance to reap the benefits without the effects of a standard dose that may interfere with daily life. As research around psychedelics as a whole continues to expand, so too does the research surrounding microdosing. A recent study from researchers at the University of Denmark looked at psilocybin, or the compound in magic mushrooms, and microdosing in rats.  Ultimately the study, published in the journal Molecular Psychiatry, found that microdosing psilocybin could offer a number of therapeutic benefits, specifically reducing stress-induced compulsive behaviors and anhedonia, the inability to feel pleasure, interest or enjoyment in life experiences. It’s no secret by now that psilocybin has been scientifically shown to carry potential in treating a number of mental health symptoms and conditions, some of which are considered treatment resistant under traditional medicine.  In the study abstract, researchers note that low-dose psychedelic use is still a lesser explored topic, especially as it pertains to its therapeutic potential — most psychedelic-assisted therapies being explored today involve larger doses with prominent effects. They also note the anecdotal evidence around the wellness benefits of microdosing psilocybin, though they say these accounts tend to be “highly biased and vulnerable to placebo effects.” To examine the effects of psilocybin microdosing, researchers housed 78 Long Evan rats in a number of experimental setups along with a proper “microdose” fit for rat brains. For the study, a dose occupying less than 20% of the rats’ 5-HT2A serotonin receptors in the brain without inducing overt behavioral changes was considered a microdose. Researchers administered a microdose on rats every other day for 24 days, examining their behaviors including anxiety levels, reaction to stress and compulsive actions in familiar and novel environments. The study found that microdosed rats in controlled studies did not exhibit increased anxiety or symptoms related to schizophrenia, and they also showed a reduction in compulsive self-grooming behavior. Researchers said this suggested a possible impact on stress-related or compulsive behaviors. Researchers also noticed similar results for rats in new environments, showing no significant increase in anxiety. Relating to stress-based anhedonia, researchers also noted that microdosed rats maintained a preference for sucrose, which showed that they hadn’t lost the ability to feel pleasure. The study also noted a lack of behavioral desensitization to psilocybin, meaning that rats’ responses to the substance was consistent over the treatment period. This is especially relevant as it relates to humans and microdosing long term for therapeutic reasons. The study also showed the microdosed rats had an increased 5-HT7 receptor expression and synaptic vesicle protein 2A levels in the brain. Researchers said this could indicate that microdosing created changes in synaptic connections and receptor expressions, meaning that low-dose psilocybin was potentially responsible for these behavioral shifts. Like any study, this one was not without its limitations. Rats are commonly used in studies as a lens to understand humans, though it’s difficult to determine how some of these findings may translate to human brains and behaviors in actuality. While the study did show a consistent response to microdosing over the research period, there’s also a remaining question surrounding a long-term psilocybin microdosing regimen and how long the effects of psilocybin would remain consistent in humans over months or even years. “These results establish a well-validated regimen for further experiments probing the effects of repeated low doses of psilocybin,” researchers said. “Results further substantiate anecdotal reports of the benefits of psilocybin microdosing as a therapeutic intervention, while pointing to a possible physiological mechanism.”

https://hightimes.com/

Trump’s White House Pharmacy Had a Bit of a Pill Problem

A lengthy new report from the Department of Defense found that during Trump’s administration, the White House Medical Unit was mishandling dangerous prescription drugs. The 80-page document released on January 8 detailed inappropriate mishandling of pharmaceuticals and their respective prescribing practices. The investigation into this matter began in 2018 after the Inspector General of the Department of Defense received complaints which included shoddy record keeping, overuse of brand name medications instead of cheaper generic alternatives, mishandling of medications such as one person picking up a prescription for another and so on.  “Without oversight from qualified pharmacy staff, the White House Medical Unit’s pharmaceutical management practices may have been subject to prescribing errors and inadequate medication management, increasing the risk to the health and safety of patients treated within the unit. Additionally, the White House Medical Unit’s pharmaceutical management practices ineffectively used DoD funds by obtaining brand‑name medications instead of generic equivalents and increased the risk for the diversion of controlled substances,” the report said. Over 120 officials were interviewed during the course of the investigation. Several witnesses gave testimony to the Department of Defense in the course of this investigation, almost all of whom described a very laissez faire environment compared to most pharmacies, or most fast food restaurants for that matter, which have all been under immense pressure from the DEA to crack down on mishandling of controlled substance. Most anyone who has tried to fill a prescription for opioid painkillers or stimulants like Adderall in the last five years can attest to this.  “Anything that took place at the White House Clinic was never written down, never recorded. [However,] the only record that you ever had that a patient came in and got any sort of medication would have been if it was a controlled substance that we were required to document for the pharmacy. But if you came in and got any other prescription medication that wasn’t classified as a controlled substance there would be no record that you came in and did anything,” one witness told the Department of Defense, while another said that it was common practice to make “go-bags” of drugs like Ambien and Provigil for White House staffers before overseas trips. In addition to mishandling of medications, the investigation found that taxpayers have been footing the bill for egregious overuse of brand name medications in lieu of their generic alternatives. Between 2017 and 2019, for instance, the White House spent $46,500 for Ambien and $98,000 for Provigil, which are 174 and 55 times more expensive, respectively, than their generic alternatives. Medical services including prescribing of controlled substances were also found to have been administered to ineligible White House staffers, on an average of six to 20 times a week according to the report.  “We found that the White House Medical Unit provided a wide range of health care and pharmaceutical services to ineligible White House staff in violation of Federal law and regulation and DoD policy. Additionally, the White House Medical Unit dispensed prescription medications, including controlled substances, to ineligible White House staff,” the report said. “We concluded that all phases of the White House Medical Unit’s pharmacy operations had severe and systemic problems due to the unit’s reliance on ineffective internal controls to ensure compliance with pharmacy safety standards,” the report said. The Department of Defense report concluded that more stringent and robust policies to prevent such issues in the future, which included establishing stricter controls for how controlled substances are prescribed and distributed as well as establishing stricter controls for who is eligible for White House medical care and who is not. “We recommend that the Director of the Defense Health Agency, in coordination with the White House Medical Unit Director, develop policy and procedures to manage controlled and non‑controlled medications, including, at a minimum, procurement, storage and inventory, prescribing and dispensing, and disposal,” the report said. “We recommend that the Director of the Defense Health Agency, in coordination with the White House Medical Unit Director, establish controls for White House patient eligibility within the Military Health System.” The complete report from the Inspector General can be found here. 

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.